Literature DB >> 12401826

Specificity of the commonly used enzymatic assay for plasma cholesterol determination.

M H Moghadasian1, J J Frohlich, C H Scudamore.   

Abstract

AIM: To assess the specificity and sensitivity of the commonly used enzymatic colorimetric test for plasma cholesterol determination.
METHODS: Interference with an enzymatic method for cholesterol measurement by several non-cholesterol sterols (beta sitosterol, campesterol, stigmasterol, stigmastanol, desmosterol, and lathosterol) was assessed. Some of these compounds are present in plasma at higher than normal concentrations either in rare genetic disorders, such as phytosterolaemia, or after the consumption of phytosterol enriched foods.
RESULTS: The non-cholesterol sterols were detected by the assay in a linear manner. There was no competitive interference in the presence of cholesterol.
CONCLUSIONS: This crossreactivity may affect the diagnosis and treatment of non-cholesterol dyslipidaemias, including phytosterolaemia and cerebrotendinous xanthomatosis. Similarly, changes in plasma lipid compositions after the consumption of phytosterol enriched foods cannot be specifically determined by this enzymatic assay. Until a more specific enzymatic assay is developed, alternative methods such as gas chromatography should be used to differentiate between cholesterol and non-cholesterol sterols.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401826      PMCID: PMC1769797          DOI: 10.1136/jcp.55.11.859

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Recommendations for the management and treatment of dyslipidemia. Report of the Working Group on Hypercholesterolemia and Other Dyslipidemias.

Authors:  J G Fodor; J J Frohlich; J J Genest; P R McPherson
Journal:  CMAJ       Date:  2000-05-16       Impact factor: 8.262

Review 3.  Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence.

Authors:  M H Moghadasian; J J Frohlich
Journal:  Am J Med       Date:  1999-12       Impact factor: 4.965

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men.

Authors:  P J Jones; F Y Ntanios; M Raeini-Sarjaz; C A Vanstone
Journal:  Am J Clin Nutr       Date:  1999-06       Impact factor: 7.045

6.  Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population.

Authors:  H Gylling; P Puska; E Vartiainen; T A Miettinen
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

7.  Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.

Authors:  M H Moghadasian; L B Nguyen; S Shefer; G Salen; A K Batta; J J Frohlich
Journal:  Metabolism       Date:  2001-06       Impact factor: 8.694

Review 8.  Sitosterolemia.

Authors:  G Salen; S Shefer; L Nguyen; G C Ness; G S Tint; V Shore
Journal:  J Lipid Res       Date:  1992-07       Impact factor: 5.922

9.  Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects.

Authors:  J A Weststrate; G W Meijer
Journal:  Eur J Clin Nutr       Date:  1998-05       Impact factor: 4.016

10.  Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects.

Authors:  H T Vanhanen; J Kajander; H Lehtovirta; T A Miettinen
Journal:  Clin Sci (Lond)       Date:  1994-07       Impact factor: 6.124

View more
  6 in total

1.  Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial.

Authors:  Parvin Dehghan; Bahram Pourghassem Gargari; Mohammad Asgharijafarabadi
Journal:  Health Promot Perspect       Date:  2013-06-30

2.  Effects of orange juice and hesperetin on serum paraoxonase activity and lipid profile in hyperuricemic rats.

Authors:  Fatemeh Haidari; Mohammad-Reza Rashidi; Majid Mohammad-Shahi
Journal:  Bioimpacts       Date:  2012-03-17

3.  Biological evaluation of a siliconized analog of clofibrate (silafibrate) in rodents.

Authors:  Mojtaba Ziaee; Mohammad Ali Eghbal; Jafar Rahmani; Mohammad Ghaffarzadeh; Arash Khorrami; Alireza Garjani
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 4.  Recent Developments of Useful MALDI Matrices for the Mass Spectrometric Characterization of Lipids.

Authors:  Jenny Leopold; Yulia Popkova; Kathrin M Engel; Jürgen Schiller
Journal:  Biomolecules       Date:  2018-12-13

5.  Case Report: Next Generation Sequencing in Clinical Practice-A Real Tool for Ending the Protracted Diagnostic Odyssey.

Authors:  Alena S Limonova; Alexandra I Ershova; Alexey N Meshkov; Anna V Kiseleva; Mikhail G Divashuk; Marina V Kurkina; Oxana M Drapkina
Journal:  Front Cardiovasc Med       Date:  2022-01-13

Review 6.  Recent advances in ABCG5 and ABCG8 variants.

Authors:  Vincent Fong; Shailendra B Patel
Journal:  Curr Opin Lipidol       Date:  2021-04-01       Impact factor: 4.776

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.